Jeleńska M - Search Results

1

Surgical treatment of hyperinsulinism during the course of pancreatic cancer (insulinoma) - one center experience.

Grygiel K, Szmidt J, Jeleńska M, Pawlak K. Grygiel K, et al. Among authors: jelenska m. Pol Przegl Chir. 2012 Jan;84(1):31-6. doi: 10.2478/v10035-012-0005-4. Pol Przegl Chir. 2012. PMID: 22472492

2

Low molecular weight heparin treatment decreases MMP-9 plasma activity in patients with abdominal aortic aneurysm.

Grzela T, Brawura-Biskupski-Samaha R, Jelenska MM, Szmidt J. Grzela T, et al. Among authors: jelenska mm. Eur J Vasc Endovasc Surg. 2008 Feb;35(2):159-61. doi: 10.1016/j.ejvs.2007.09.008. Epub 2007 Oct 26. Eur J Vasc Endovasc Surg. 2008. PMID: 17964826 Free article. Clinical Trial.

3

Persisted/recurrent hyperparathyroidism associated with development of multi-drug resistance phenotype and proliferation of parathyroid transplants.

Grzela T, Chudzinski W, Lazarczyk M, Niderla J, Dziunycz P, Milewski L, Samaha R, Kobylecka M, Miskiewicz J, Bogacka-Zatorska E, Gornicka B, Swiercz P, Jelenska M, Krolicki L. Grzela T, et al. Among authors: jelenska m. Int J Mol Med. 2004 Oct;14(4):595-9. Int J Mol Med. 2004. PMID: 15375587

4

[Hemorrhagic parapneumonic effusion in a 64 year-old patient as the first symptom of hemophilia B].

Grabczak EM, Krenke R, Jeleńska M, Komarow I, Ambroziak U, Fangrat A, Chazan R. Grabczak EM, et al. Among authors: jelenska m. Pneumonol Alergol Pol. 2009;77(3):320-6. Pneumonol Alergol Pol. 2009. PMID: 19591107 Free article. Polish.

5

Compensated activation of coagulation in patients with abdominal aortic aneurysm: effects of heparin treatment prior to elective surgery.

Jelenska MM, Szmidt J, Bojakowski K, Grzela T, Palester-Chlebowczyk M. Jelenska MM, et al. Thromb Haemost. 2004 Nov;92(5):997-1002. doi: 10.1160/TH03-10-0665. Thromb Haemost. 2004. PMID: 15543326 Clinical Trial.

6

Coagulation parameters as predictors of DIC in patients with intact aortic aneurysm.

Jeleńska MM. Jeleńska MM. Hamostaseologie. 2004 Aug;24(3):162-6. doi: 10.1267/hamo04030162. Hamostaseologie. 2004. PMID: 15314700 Review.

7

Can low level of von Willebrand factor decrease the risk of thrombosis in families with antithrombin or protein C deficiency?

Jelenska MM, Palester-Chlebowczyk M, Grochowiecki R, Zajac S. Jelenska MM, et al. Thromb Haemost. 1999 May;81(5):846-7. Thromb Haemost. 1999. PMID: 10365764 No abstract available.

8

Cathepsin G can be responsible for von Willebrand factor degradation in whole blood during storage.

Jeleńska MM, Kopeć M, Scharrer I, Breddin K. Jeleńska MM, et al. Transfus Med. 1995 Sep;5(3):241-2. doi: 10.1111/j.1365-3148.1995.tb00234.x. Transfus Med. 1995. PMID: 8593530 No abstract available.

9

Fibrinogen does not protect von Willebrand factor against proteolysis by human cathepsin G.

Jeleńska M, Kopeć M, Sopata I, Vigh Z, Scharrer I, Breddin K. Jeleńska M, et al. Thromb Res. 1991 Feb 15;61(4):433-40. doi: 10.1016/0049-3848(91)90657-i. Thromb Res. 1991. PMID: 1905850

10

[Von Willebrand's disease].

Jeleńska MM. Jeleńska MM. Pol Arch Med Wewn. 1990 Aug;84(2):105-13. Pol Arch Med Wewn. 1990. PMID: 2277781 Review. Polish. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27 results

Search Page

Filters